Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow (original) (raw)

• Lanzavecchia, A. & Sallusto, F. From synapses to immunological memory: the role of sustained T cell stimulation. Curr. Opin. Immunol. 12, 92–98 (2000).
  Article CAS PubMed Google Scholar
• Goldrath, A.W. & Bevan, M.J. Selecting and maintaining a diverse T-cell repertoire. Nature (Lond.). 402, 255–262 (1999).
  Article CAS Google Scholar
• Zinkernagel, R.M. et al. On immunological memory. Annu. Rev. Immunol. 14, 333–367 (1996).
  Article CAS PubMed Google Scholar
• Sallusto, F., Lenig, D., Förster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 402, 708–712 (1999).
  Article Google Scholar
• Hamann, D. et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186, 1407–1418 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Veiga-Fernandes, H., Walter, U., Bourgeois, C., McLean, A. & Rocha, B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nature Immunol. 1, 47–53 (2000).
  Article CAS Google Scholar
• Sprent, J., Tough, D.F. & Sun, S. Factors controlling the turnover of T memory cells. Immunol. Rev. 156, 79–85 (1997).
  Article CAS PubMed Google Scholar
• Tanchot, C., Lemonnier, F.A., Perarnau, B., Freitas, A.A. & Rocha, B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276, 2057–2062 (1997).
  Article CAS PubMed Google Scholar
• Garcia, S., DiSanto, J. & Stockinger, B. Following the development of a CD4 T cell immune response in vivo: from activation to memory formation. Immunity 11, 163–171 (1999).
  Article CAS PubMed Google Scholar
• Khazaie, K. et al. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. Proc. Natl. Acad. Sci. USA 91, 7430–7434 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Müller, M. et al. Eb-lacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res. 58, 5439–5446 (1998).
  PubMed Google Scholar
• Pantel, K., Cote, R.J. & Fodstad, O. Detection and clinical importance of micrometastatic disease. J. Natl. Cancer Inst. 91, 1113–1124 (1999).
  Article CAS PubMed Google Scholar
• Feuerer, M. et al. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients. Int. J. Cancer 92, 96–105 (2001).
  Article CAS PubMed Google Scholar
• Fisk, B., Blevins, T.L., Wharton, J.T. & Ioannides, C.G. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med. 181, 2109–2117 (1995).
  Article CAS PubMed Google Scholar
• Brossart, P. et al. Identification of HLA-A2-restricted T-cell epitopes derived from MUC1 tumor antigen for broadly applicable vaccine therapies. Blood 93, 4309–4317 (1999).
  CAS PubMed Google Scholar
• Tsomides, T.J. et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180, 1283–1293 (1994).
  Article CAS PubMed Google Scholar
• Schultz, L.D. et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180–191 (1995).
  Google Scholar
• Visonneau, S. Cesano, A., Torosian, M.H., Miller, E.J. & Santoli, D. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. Am. J. Pathol. 152, 1299–1311 (1998).
  CAS PubMed PubMed Central Google Scholar
• Slavin, S. et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse post allogeneic bone marrow transplantation. Blood 87, 2195–2204 (1996).
  CAS PubMed Google Scholar
• Rosenberg, S.A. et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjuction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J. Natl. Cancer Inst. 85, 622–632 (1993).
  Article CAS PubMed Google Scholar
• Rosenberg, S.A. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10, 281–287 (1999).
  Article CAS PubMed Google Scholar
• Schirrmacher, V., Schild, H.J., Gückel, B. & von Hoegen, P. Tumor specific CTL response requiring interactions of four different cell types and dual recognition of MHC class I and class II restricted tumor antigens. Immunol. Cell Biol. 71, 311–326 (1992).
  Article Google Scholar
• Singh-Jasuja, H. et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of ist receptor. Eur. J. Immunol. 30, 2211–2215 (2000).
  Article CAS PubMed Google Scholar
• Sauter, B. et al. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423–433 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gilboa, E. The making of a tumor rejection antigen. Immunity 11, 263–270 (1999).
  Article CAS PubMed Google Scholar
• Finn, O.J. et al. MUC1 epithelial tumor-mucin-based immunity and cancer vaccines. Immunol.Rev. 145, 61–89 (1995).
  Article CAS PubMed Google Scholar
• Disis, M.L., Grabstein, K.H., Sleath, D.R. & Cheever, M.A. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide–based vaccine. Clin. Cancer Res. 5, 1289–1297 (1999).
  CAS PubMed Google Scholar
• Fields, R.C., Shimizu, K. & Mule, J.J. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 96, 8639–8644 (1999).
  Article Google Scholar
• Müerköster, S. et al. Graft-versus-Leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Clin. Cancer Res. 4, 3095–3106 (1998).
  PubMed Google Scholar
• Lee, P.D. et al. Charcterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature Med. 5, 677–685 (1999).
  Article CAS PubMed Google Scholar
• Valmori, D. et al. Naturally occuring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res. 60, 4499–4506 (2000).
  CAS PubMed Google Scholar
• Paramithiotis, E. & Cooper, M.D. Memory B lymphocytes migrate to bone marrow in humans. Proc. Natl. Acad. Sci. USA 94, 208–212 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Slifka, M.K., Whitmire, J.K. & Ahmed, R. Bone marrow contains virus-specific cytotoxic T lymphocytes. Blood 90, 2103–2108 (1997).
  CAS PubMed Google Scholar
• Price, P.W. & Cerny, J. Characterization of CD4+ T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR V-β repertoire. Eur. J. Immunol. 29, 1051–1056 (1999).
  Article CAS PubMed Google Scholar
• Kuroda, M.J. et al. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. Blood 96, 1474–1479 (2000).
  CAS PubMed Google Scholar
• Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G.V. & Wolf, N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. USA 92, 9647–9651 (1997).
  Article Google Scholar
• Briskin, M.J. et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151, 97–110 (1997).
  CAS PubMed PubMed Central Google Scholar
• Berlin, C. et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74, 185–195 (1993).
  Article CAS PubMed Google Scholar
• Erle, D.J. et al. Expression and function of the MAdCAM-1 receptor, integrin α4β7, on human leucocytes. J. Immunol. 153, 517–528.
• Nestle, F.O. et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med. 4, 328–332 (1998).
  Article CAS PubMed Google Scholar
• Kugler, A. et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nature Med. 6, 332–336 (2000).
  Article CAS PubMed Google Scholar
• Diel, K.J. et al. Micrometastatic breast cancer cells in bone marrow at primary surgery - prognostic value in comparison to nodal status. J. Natl. Cancer Inst. 88, 1652–1658 (1996).
  Article CAS PubMed Google Scholar
• Schuler, G. et al. in Dendritic cells (eds. Lotze, M.T. & Thomson, A.W.) 515–534 (Academic Press, San Diego, California, 1999).
  Google Scholar
• Lalvani, A. et al. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186, 859–865 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Brossart, P. & Bevan, M.J. Selective activation of Fas/FasL mediated cytotoxicity by a self-peptide. J. Exp. Med. 183, 2449–2458 (1996).
  Article CAS PubMed Google Scholar